• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UBASH3B是一种新型的预后生物标志物,与前列腺癌中的免疫浸润相关。

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.

作者信息

Wang Zijun, Wang Yinhuai, Peng Mou, Yi Lu

机构信息

Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China.

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Oncol. 2020 Jan 15;9:1517. doi: 10.3389/fonc.2019.01517. eCollection 2019.

DOI:10.3389/fonc.2019.01517
PMID:32010618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6974685/
Abstract

UBASH3B (STS1) is an important gene that negatively regulates T-cell receptor signaling in activated T-lymphocytes that involved in cancers. However, the function of UBASH3B in prostate cancer (PCa) and the correlation between UBASH3B and tumor-infiltrating immune cells still remain unclear. Real-time PCR and immunohistochemistry were applied to detect mRNA and protein expression of UBASH3B in PCa patients and benign prostate hyperplasia patients (BPH). Clinical features of patients with PCa were recorded and Kaplan Meier curve was subsequently plotted. Based on mRNA expression of UBASH3B, patients with PCa from TCGA database were divided into low-UBASH3B-expression group and high-UBASH3B-expression group for construct lncRNA-miRNA-mRNA network and analyzing GO and KEGG pathways. Single gene analysis method was performed by using GSEA to interpret gene expression data in PCa. The PPI network was constructed using STRING and the correlation between UBASH3B and tumor-infiltrating immune cells was analyzed by TIMER and CIBERSORT. The mRNA and protein expression of UBASH3B were upregulated in PCa. The abundant expression of UBASH3B is associated with poor prognosis in PCa. The subnetwork of UBASH3B contains three lncRNAs (MIAT, LINC01297, MYLK-AS1) and four miRNAs (hsa-miR-200a-3p, hsa-miR-455-5p, hsa-miR-192-5p, hsamiR- 215-5P). The mRNA expression of UBASH3B was involved in 28 KEGG pathways. GSEA analysis showed that 18 hallmark gene sets were significantly enriched in high-UBASH3B-expression, whereas 1 gene set was enriched in low-UBASH3B-expression. PPI network revealed a tightly interaction between UBASH3B and LCP2 (an immune related gene). TIMER and CIBERSORT database indicated that UBASH3B was correlated with 11 types of tumor-infiltrating immune cells (naïve B cell, memory B cells, resting CD4 memory T cell, activated CD4 memory T cell, regulatory T cell, activated NK cell, M2 macrophages, resting dendritic cells, activated dendritic cells, resting mast cells, neutrophils). In conclusion, UBASH3B may be a novel potential prognostic biomarker and is associated with tumor-infiltrating immune cells in tumor microenvironment, suggesting UBASH3B as a potential target for future treatment of PCa.

摘要

泛素相关SH3结构域蛋白3B(UBASH3B,又称STS1)是一个重要基因,它在参与癌症的活化T淋巴细胞中对T细胞受体信号传导起负调控作用。然而,UBASH3B在前列腺癌(PCa)中的功能以及UBASH3B与肿瘤浸润免疫细胞之间的相关性仍不清楚。应用实时聚合酶链反应(PCR)和免疫组织化学方法检测PCa患者和良性前列腺增生患者(BPH)中UBASH3B的mRNA和蛋白表达。记录PCa患者的临床特征,随后绘制Kaplan-Meier曲线。基于TCGA数据库中UBASH3B的mRNA表达,将PCa患者分为低UBASH3B表达组和高UBASH3B表达组,以构建lncRNA-miRNA-mRNA网络并分析基因本体(GO)和京都基因与基因组百科全书(KEGG)通路。使用基因集富集分析(GSEA)通过单基因分析方法解释PCa中的基因表达数据。利用STRING构建蛋白质-蛋白质相互作用(PPI)网络,并通过TIMER和CIBERSORT分析UBASH3B与肿瘤浸润免疫细胞之间的相关性。PCa中UBASH3B的mRNA和蛋白表达上调。UBASH3B的高表达与PCa的不良预后相关。UBASH3B的子网络包含三个长链非编码RNA(MIAT、LINC01297、MYLK-AS1)和四个微小RNA(hsa-miR-200a-3p、hsa-miR-455-5p、hsa-miR-192-5p、hsa-miR-215-5P)。UBASH3B的mRNA表达参与28条KEGG通路。GSEA分析显示,18个标志性基因集在高UBASH3B表达中显著富集,而1个基因集在低UBASH3B表达中富集。PPI网络揭示UBASH3B与LCP2(一个免疫相关基因)之间存在紧密相互作用。TIMER和CIBERSORT数据库表明,UBASH3B与11种肿瘤浸润免疫细胞(初始B细胞、记忆B细胞、静息CD4记忆T细胞、活化CD4记忆T细胞、调节性T细胞、活化自然杀伤细胞、M2巨噬细胞、静息树突状细胞、活化树突状细胞、静息肥大细胞、中性粒细胞)相关。总之,UBASH3B可能是一种新型潜在预后生物标志物,并且与肿瘤微环境中的肿瘤浸润免疫细胞相关,提示UBASH3B作为PCa未来治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/d266d7d3535a/fonc-09-01517-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/b51cd750c034/fonc-09-01517-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/e458a6e12baf/fonc-09-01517-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/a7dc33530e88/fonc-09-01517-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/ed106d797d52/fonc-09-01517-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/cf6346459727/fonc-09-01517-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/45d342b3f1a3/fonc-09-01517-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/d266d7d3535a/fonc-09-01517-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/b51cd750c034/fonc-09-01517-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/e458a6e12baf/fonc-09-01517-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/a7dc33530e88/fonc-09-01517-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/ed106d797d52/fonc-09-01517-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/cf6346459727/fonc-09-01517-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/45d342b3f1a3/fonc-09-01517-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8b/6974685/d266d7d3535a/fonc-09-01517-g0007.jpg

相似文献

1
UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.UBASH3B是一种新型的预后生物标志物,与前列腺癌中的免疫浸润相关。
Front Oncol. 2020 Jan 15;9:1517. doi: 10.3389/fonc.2019.01517. eCollection 2019.
2
The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.促侵袭因子COL6A2作为胶质瘤的一种新型预后标志物。
Front Oncol. 2022 Nov 25;12:897042. doi: 10.3389/fonc.2022.897042. eCollection 2022.
3
LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer.长链非编码RNA MIAT作为乳腺癌诊断的无创生物标志物并与免疫浸润相关
Int J Womens Health. 2021 Oct 22;13:991-1004. doi: 10.2147/IJWH.S312714. eCollection 2021.
4
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.BICC1 作为一种新型胃癌预后生物标志物,与免疫浸润相关。
Int Immunopharmacol. 2020 Oct;87:106828. doi: 10.1016/j.intimp.2020.106828. Epub 2020 Jul 28.
5
Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer.新型长链非编码RNA ZFHX4-AS1作为一种潜在的预后生物标志物,影响卵巢癌的免疫微环境。
Front Oncol. 2022 Jul 12;12:945518. doi: 10.3389/fonc.2022.945518. eCollection 2022.
6
Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4 T cells.吉西他滨耐药胰腺癌细胞中激活的miRNA-mRNA网络与记忆性CD4 T细胞的改变有关。
Ann Transl Med. 2020 Mar;8(6):279. doi: 10.21037/atm.2020.03.53.
7
Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.肝细胞癌中MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA网络轴的综合分析
Discov Oncol. 2021 Oct 7;12(1):38. doi: 10.1007/s12672-021-00436-3.
8
The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.复发性软组织肉瘤中肿瘤浸润免疫细胞和ceRNA网络的构建与分析
Aging (Albany NY). 2019 Nov 18;11(22):10116-10143. doi: 10.18632/aging.102424.
9
MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.MYBL2是一种新型独立预后生物标志物,与前列腺癌中的免疫浸润相关。
Int J Gen Med. 2022 Mar 15;15:3003-3030. doi: 10.2147/IJGM.S351638. eCollection 2022.
10
Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.RAD51 在人乳腺癌中的预后和免疫浸润的综合分析。
Crit Rev Eukaryot Gene Expr. 2021;31(4):71-79. doi: 10.1615/CritRevEukaryotGeneExpr.2021038876.

引用本文的文献

1
Investigating the role of UBASH3B in cancer: structural relevance, physiological functions, and therapeutic possibilities.探究UBASH3B在癌症中的作用:结构相关性、生理功能及治疗潜力
J Exp Clin Cancer Res. 2025 Aug 30;44(1):262. doi: 10.1186/s13046-025-03511-7.
2
Interpretable machine learning driven biomarker identification and validation for prostate cancer.可解释的机器学习驱动的前列腺癌生物标志物识别与验证
Transl Androl Urol. 2025 Jun 30;14(6):1528-1541. doi: 10.21037/tau-2025-242. Epub 2025 Jun 26.
3
Innate immune cell barrier-related genes inform precision prognosis in pancreatic cancer.

本文引用的文献

1
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.TNFR2/BIRC3-TRAF1信号通路作为癌症中一种新型的自然杀伤细胞免疫检查点
Oncoimmunology. 2017 Oct 11;7(12):e1386826. doi: 10.1080/2162402X.2017.1386826. eCollection 2018.
2
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.深入了解 BIRC3:肝癌的新型预后指标和潜在治疗靶点。
J Cell Biochem. 2019 Apr;120(4):6035-6045. doi: 10.1002/jcb.27890. Epub 2018 Oct 28.
3
UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1.
先天性免疫细胞屏障相关基因可为胰腺癌的精准预后提供信息。
Front Immunol. 2025 May 23;16:1559373. doi: 10.3389/fimmu.2025.1559373. eCollection 2025.
4
Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer.前列腺癌中涉及免疫亚群、浸润和长链非编码RNA的竞争性内源性RNA网络
Genes (Basel). 2025 Apr 29;16(5):527. doi: 10.3390/genes16050527.
5
Advances in Prostate Cancer Biomarkers and Probes.前列腺癌生物标志物与探针的进展
Cyborg Bionic Syst. 2024 Jun 27;5:0129. doi: 10.34133/cbsystems.0129. eCollection 2024.
6
Proteogenomic Profiling Reveals Small ORFs and Functional Microproteins in Activated T Cells.蛋白质基因组分析揭示活化T细胞中的小开放阅读框和功能性微蛋白。
Mol Cell Proteomics. 2025 Feb 4:100914. doi: 10.1016/j.mcpro.2025.100914.
7
UBASH3B-mediated MRPL12 Y60 dephosphorylation inhibits LUAD development by driving mitochondrial metabolism reprogramming.UBASH3B 介导的 MRPL12 Y60 去磷酸化通过驱动线粒体代谢重编程抑制 LUAD 的发展。
J Exp Clin Cancer Res. 2024 Sep 30;43(1):268. doi: 10.1186/s13046-024-03181-x.
8
LncRNA PITPNA-AS1 mediates the diagnostic potential of miR-129-5p in prostate cancer.长链非编码 RNA PITPNA-AS1 介导 miR-129-5p 在前列腺癌中的诊断潜力。
BMC Urol. 2024 Jul 13;24(1):146. doi: 10.1186/s12894-024-01528-2.
9
The Ubiquitin-Associated and SH3 Domain-Containing Proteins (UBASH3) Family in Mammalian Development and Immune Response.哺乳动物发育和免疫反应中的泛素相关和 SH3 结构域蛋白(UBASH3)家族。
Int J Mol Sci. 2024 Feb 5;25(3):1932. doi: 10.3390/ijms25031932.
10
Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease.基因表达分析显示,冷凝集素病克隆性B细胞中补体受体1表达下调。
Clin Exp Immunol. 2024 Mar 12;216(1):45-54. doi: 10.1093/cei/uxad135.
UBASH3B促进他莫昔芬耐药,且可能受ESR1负调控。
Oncotarget. 2017 Dec 22;9(9):8326-8333. doi: 10.18632/oncotarget.23608. eCollection 2018 Feb 2.
4
Profiling Tumor Infiltrating Immune Cells with CIBERSORT.使用CIBERSORT分析肿瘤浸润免疫细胞
Methods Mol Biol. 2018;1711:243-259. doi: 10.1007/978-1-4939-7493-1_12.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.TIMER:用于肿瘤浸润免疫细胞综合分析的网络服务器。
Cancer Res. 2017 Nov 1;77(21):e108-e110. doi: 10.1158/0008-5472.CAN-17-0307.
7
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.低PCA3表达是局限性前列腺肿瘤分化不良的一个标志物:来自12076例患者的探索性分析。
Oncotarget. 2017 Feb 7;8(31):50804-50813. doi: 10.18632/oncotarget.15133. eCollection 2017 Aug 1.
8
Identification of STS-1 as a novel ShcA-binding protein.鉴定STS-1为一种新型的ShcA结合蛋白。
Biochem Biophys Res Commun. 2017 Sep 2;490(4):1334-1339. doi: 10.1016/j.bbrc.2017.07.024. Epub 2017 Jul 6.
9
Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.一种新型候选致癌基因KIF14的过表达与前列腺癌的肿瘤进展和不良预后相关。
Oncotarget. 2017 Jul 11;8(28):45459-45469. doi: 10.18632/oncotarget.17564.
10
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.通过靶向骨髓细胞中的PI3Kγ克服对检查点阻断疗法的耐药性。
Nature. 2016 Nov 17;539(7629):443-447. doi: 10.1038/nature20554. Epub 2016 Nov 9.